# A Multi-Institutional Case Series of Neonatal Lupus Erythematosus Without Cardiac Involvement From Vietnam

**Authors:** Cong Mai Thanh, Phuoc Nguyen Trong, Lien Luong Thi, Ha Nguyen Thi

PMC · DOI: 10.1155/crpe/5727878 · Case Reports in Pediatrics · 2025-10-13

## TL;DR

This paper presents six cases of neonatal lupus in Vietnam without heart issues, showing how they were diagnosed and successfully treated.

## Contribution

The study provides a rare case series of NLE without cardiac involvement from Vietnam, highlighting clinical features and treatment outcomes.

## Key findings

- All six patients showed skin rash, with other common symptoms including anemia and low platelet counts.
- Most patients tested positive for anti-SSA and anti-SSB antibodies, and all recovered fully with treatments like IVIG or steroids.
- No long-term complications were observed in any of the patients after treatment.

## Abstract

Neonatal lupus erythematosus (NLE) is a rare autoimmune disease in newborns and infants, caused by the transplacental transmission of anti-Sjögren's syndrome–related antigen A (anti-SSA), anti-Sjögren's syndrome–related antigen B (anti-SSB), and anti-ribonucleoprotein (anti-RNP) maternal antibodies to fetal tissues during pregnancy, with manifestations in the skin, heart, liver, and hematologic systems. While cardiac abnormalities in NLE, primarily congenital heart block, may be detected prenatally through fetal echocardiography, noncardiac manifestations become evident after birth and can be easily missed due to their nonspecific nature. In this report, we describe six cases of NLE without cardiac involvement, diagnosed and managed by our team across three hospitals in Hanoi, Vietnam, between 2018 and 2023, with patient ages at diagnosis ranging from 40 days to 7 months. Clinical and laboratory findings include skin rash (6/6), anemia (5/6), thrombocytopenia (3/6), neutropenia (3/6), elevated liver enzymes (2/6), hypocomplementemia (4/5), and positivity for anti-SSA (5/6), anti-SSB (4/6), and anti-RNP (2/6) antibodies. Treatment approaches consisted of intravenous immunoglobulin (IVIG) in three cases, oral corticosteroids in one case, topical corticosteroids in one case, and supportive care without specific treatment in one case. All patients demonstrated full clinical recovery without any residual sequelae.

## Linked entities

- **Diseases:** Neonatal lupus erythematosus (MONDO:0018360), congenital heart block (MONDO:0009326)

## Full-text entities

- **Genes:** TRIM21 (tripartite motif containing 21) [NCBI Gene 6737] {aka RNF81, RO52, Ro/SSA, SSA, SSA1, TRIM21/Ro52}, RNPC3 (RNA binding region (RNP1, RRM) containing 3) [NCBI Gene 55599] {aka CPHD7, IGHD5, RBM40, RNP, SNRNP65}, SSB (small RNA binding exonuclease protection factor La) [NCBI Gene 6741] {aka LARP3, La, La/SSB, SSB/La}
- **Diseases:** autoimmune disease (MESH:D001327), anemia (MESH:D000740), congenital heart block (MESH:C535758), thrombocytopenia (MESH:D013921), skin rash (MESH:D005076), neutropenia (MESH:D009503), NLE (MESH:C536397), cardiac abnormalities (MESH:D018376), Cardiac Involvement (MESH:D006331)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12537213/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12537213/full.md

## References

12 references — full list in the complete paper: https://tomesphere.com/paper/PMC12537213/full.md

---
Source: https://tomesphere.com/paper/PMC12537213